Skip to content

Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling

Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030861
Enrollment
Unknown
Registered
2020-03-16
Start date
2019-02-27
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of the Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Stage I and ii healthy subjects Stage 3: 1. Clinical manifestations: (1) Fever; (2) normal or decreased white blood cells; (3) CT pulmonary exudation; Or a suspected patient with an epidemiological history; 2. Isolation ward: patients with novel coronavirus (mild, common).

Exclusion criteria

Exclusion criteria: Stage 1 and stage 2: subjects who cannot cooperate; Patients with fever, cough and expectoration in recent 2 weeks; Patients with underlying diseases. Stage 3: 1. Patients who cannot cooperate with the throat swab examination; 2. Three patients who are not consistent with clinical manifestations at the same time and not suspected of novel coronavirus; 3. Patients considered inappropriate by the researcher; 4. Patients with severe or unstable vital signs with novel coronavirus.

Design outcomes

Primary

MeasureTime frame
CT;

Contacts

Public ContactShiyue Li

The First Affiliated Hospital of the Guangzhou Medical University

lishiyue@188.com+86 13902233925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026